SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio -- Ignore unavailable to you. Want to Upgrade?


To: nigel bates who wrote (698)9/6/2002 7:38:49 PM
From: tuck  Read Replies (1) | Respond to of 1005
 
Despite what Pat Benatar thinks, Hell is not for children -- largely because they'd be adults before they get out of it. Arena, and most others here, are still frying . . .

>>Friday September 6, 4:54 pm ET

WASHINGTON -(Dow Jones)- Tripos Inc. (NasdaqNM:TRPS - News) sold 41,334 shares of Arena Pharmaceuticals Inc. (NasdaqNM:ARNA - News) common stock in August, according to a Form 4 released Friday by the Securities and Exchange Commission.

Tripos sold the shares Aug. 16 to Aug. 30 for $6.37 to $6.65 a share. At the end of August, Tripos owned 1.6 million shares of Arena Pharmaceuticals.<<

snip

Plenty of overhang left over Arena.

Cheers, Tuck